Aligos Therapeutics (ALGS) Asset Utilization Ratio (2021 - 2026)

Aligos Therapeutics has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.06 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 110.21% year-over-year to 0.06; the trailing twelve-month figure through Mar 2026 stood at 0.06 (up 110.21% YoY), and the FY2025 full-year result was 0.03, down 15.42% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.06, up from 0.02 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.13 in Q3 2023, with the low at 0.02 in Q3 2022.
• Historically, Asset Utilization Ratio has averaged 0.05 across 5 years, with a median of 0.05 in 2024.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 672.28% — and 2025, when it sank 68.99%.
• Aligos Therapeutics' Asset Utilization Ratio stood at 0.04 in 2022, then soared by 175.42% to 0.11 in 2023, then slumped by 57.92% to 0.05 in 2024, then sank by 51.61% to 0.02 in 2025, then surged by 178.79% to 0.06 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.06 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.